PlainPharmaWatch

CMS Open Payments · Tool

LivaNova USA, Inc. vs Henry Schein, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Henry Schein, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,520, versus 7,836 for the other company. Its single largest recorded recipient represents 97.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

LivaNova USA, Inc.
HHI 7,836 · top recipient 88.5%
Ranked #197 of 1,838 companies by HHI
Henry Schein, Inc.
HHI 9,520 · top recipient 97.6%
Ranked #154 of 1,838 companies by HHI

Payment Overview

Company A

LivaNova USA, Inc.

Total Payments
$26.3M
% of Industry
0.2%
Transactions
10,999
Avg per Transaction
$2.4K
Recipients
8,622
Avg per Recipient
$3.1K
Payment Types
9
Top Payment Type
Royalty or License
Company B

Henry Schein, Inc.

Total Payments
$27.4M
% of Industry
0.2%
Transactions
2,793
Avg per Transaction
$9.8K
Recipients
2,793
Avg per Recipient
$9.8K
Payment Types
10
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

LivaNova USA, Inc. vs Henry Schein, Inc. - total reported payments in CMS Open Payments PY2024

Henry Schein, Inc.$27.4MLivaNova USA, Inc.$26.3M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

LivaNova USA, Inc.

Royalty or License $17.5M

88.5%

Compensation for Services Other Than Consulting $893.0K

4.5%

Travel and Lodging $503.5K

2.6%

Food and Beverage $363.3K

1.8%

Debt Forgiveness $303.6K

1.5%

Honoraria $83.0K

0.4%

Henry Schein, Inc.

Acquisitions $26.7M

97.6%

Compensation for Faculty or Speaker (Medical Education) $171.6K

0.6%

Travel and Lodging $159.1K

0.6%

Consulting Fee $131.2K

0.5%

Compensation for Services Other Than Consulting $105.1K

0.4%

Food and Beverage $87.2K

0.3%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

LivaNova USA, Inc.

  1. 1

    IVAN OSORIO

    $17,456,052.97 · 5 txns

  2. 2

    AHMED ABDELMOITY

    $174,428.84 · 219 txns

  3. 3

    AUGUSTUS RUSH

    $169,053.91 · 103 txns

  4. 4

    DANIELLE BECKER

    $109,099.51 · 123 txns

  5. 5

    KATHRYN A. POLOVITZ

    $58,369.34 · 88 txns

Henry Schein, Inc.

  1. 1

    ROBERT MEDOFF

    $26,746,121.23 · 5 txns

  2. 2

    KERRY SULKOWICZ

    $92,658.10 · 13 txns

  3. 3

    JIANING HE

    $21,761.93 · 10 txns

  4. 4

    JOHN YU

    $12,104.54 · 4 txns

  5. 5

    JEFFREY GELFAND

    $12,000.00 · 4 txns

Summary Comparison

Metric LivaNova USA, Inc. Henry Schein, Inc.
Total Payments $26.3M $27.4M
% of Industry Total 0.2% 0.2%
Transaction Count 10,999 2,793
Avg per Transaction $2.4K $9.8K
Recipient Count 8,622 2,793
Avg per Recipient $3.1K $9.8K
Payment Type Count 9 10
Top Payment Type Royalty or License Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.